Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TDP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CHMP2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSE1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTPAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENSA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOPORS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEMIN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CFAP97 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEK7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABCE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT80 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPDL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2K - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PBRM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR3F - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on